{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:26:05Z","timestamp":1772601965136,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s11906-007-0088-1","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T15:44:49Z","timestamp":1203090289000},"page":"480-485","source":"Crossref","is-referenced-by-count":170,"title":["Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia"],"prefix":"10.1007","volume":"9","author":[{"given":"Babbette D.","family":"LaMarca","sequence":"first","affiliation":[]},{"given":"Michael J.","family":"Ryan","sequence":"additional","affiliation":[]},{"given":"Jeffrey S.","family":"Gilbert","sequence":"additional","affiliation":[]},{"given":"Sydney R.","family":"Murphy","sequence":"additional","affiliation":[]},{"given":"Joey P.","family":"Granger","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,2,16]]},"reference":[{"key":"88_CR1","first-page":"69","volume":"58","author":"L. Poston","year":"2006","unstructured":"Poston L: Endothelial dysfunction in preeclampsia. Pharmacol Rep 2006, 58:69\u201374.","journal-title":"Pharmacol Rep"},{"key":"88_CR2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.semnephrol.2004.07.002","volume":"24","author":"M.T. McMaster","year":"2004","unstructured":"McMaster MT, Ahou Y, Fisher SJ: Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 2004, 24:540\u2013547.","journal-title":"Semin Nephrol"},{"key":"88_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0897.2007.00486.x","volume":"58","author":"A. Sharma","year":"2007","unstructured":"Sharma A, Satyam A, Sharma JB: Leptin, IL-10, and inflammatory markers (TNF-alpha, IL-6 and IL-8) in preeclamptic, normotensive pregnant and healthy nonpregnant women. Am J Reprod Immunol 2007, 58:21\u201330.","journal-title":"Am J Reprod Immunol"},{"key":"88_CR4","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","volume":"203","author":"G. Girardi","year":"2006","unstructured":"Girardi G, Yarilin D, Thurman JM, et al.: Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006, 203:2165\u20132175.","journal-title":"J Exp Med"},{"key":"88_CR5","doi-asserted-by":"crossref","first-page":"H935","DOI":"10.1152\/ajpheart.00708.2005","volume":"288","author":"D.L. Lee","year":"2006","unstructured":"Lee DL, Sturgis LC, Labazi H, et al.: Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 2006, 288:H935\u2013H940.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"88_CR6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.HYP.0000238442.33463.94","volume":"48","author":"G. Gadonski","year":"2006","unstructured":"Gadonski G, LaMarca BB, Sullivan E, et al.: Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin-6. Hypertension 2006, 48:711\u2013716.","journal-title":"Hypertension"},{"key":"88_CR7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.HYP.0000169152.59854.36","volume":"46","author":"B.B. LaMarca","year":"2005","unstructured":"LaMarca BB, Cockrell K, Sullivan E, et al.: Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 2005, 46:82\u201386.","journal-title":"Hypertension"},{"key":"88_CR8","first-page":"557","volume":"21","author":"N. Maruotti","year":"2006","unstructured":"Maruotti N, Canatore FP, Crivellato E, et al.: Angiogenesis in rheumatoid arthritis. Histol Histopathol 2006, 21:557\u2013566.","journal-title":"Histol Histopathol"},{"key":"88_CR9","first-page":"383","volume":"122","author":"J.P. Granger","year":"2006","unstructured":"Granger JP, LaMarca BBD, Cockrell K, et al.: Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 2006, 122:383\u2013392.","journal-title":"Methods Mol Med"},{"key":"88_CR10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.HYP.0000175476.26719.36","volume":"46","author":"B.B.D. LaMarca","year":"2005","unstructured":"LaMarca BBD, Bennett WA, Alexander BT, et al.: Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor alpha. Hypertension 2005, 46:1022\u201310225.","journal-title":"Hypertension"},{"key":"88_CR11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.HYP.0000197950.42301.dd","volume":"47","author":"L. Roberts","year":"2006","unstructured":"Roberts L, LaMarca B, Fournier L, et al.: Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 2006, 47:615\u2013618.","journal-title":"Hypertension"},{"key":"88_CR12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.semnephrol.2004.07.003","volume":"24","author":"Y. Bdolah","year":"2004","unstructured":"Bdolah Y, Sukhatme VP, Karumanchi SA: Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights. Semin Nephrol 2004, 24:548\u2013556.","journal-title":"Semin Nephrol"},{"key":"88_CR13","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1210\/jc.2004-1955","volume":"90","author":"E. Shibata","year":"2005","unstructured":"Shibata E, Rajakumar A, Powers RW, et al.: Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005, 90:4895\u20134903.","journal-title":"J Clin Endocrinol Metab"},{"key":"88_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajog.2005.03.016","volume":"193","author":"M. Wolf","year":"2005","unstructured":"Wolf M, Shah A, Lam C, et al.: Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol 2005, 193:16\u201322.","journal-title":"Am J Obstet Gynecol"},{"key":"88_CR15","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","volume":"57","author":"S.E. Maynard","year":"2005","unstructured":"Maynard SE, Venkatesha S, Thadhani R, et al.: Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res 2005, 57:1R\u20137R.","journal-title":"Pediatr Res"},{"key":"88_CR16","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2004-1028","volume":"145","author":"S.A. Karumanchi","year":"2004","unstructured":"Karumanchi SA, Bdolah Y: Hypoxia and sFlt-1 in preeclampsia: the \u201cchicken-and-egg\u201d question. Endocrinology 2004, 145:4835\u20134837.","journal-title":"Endocrinology"},{"key":"88_CR17","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1523-1755.2005.00316.x","volume":"67","author":"S.A. Karumanchi","year":"2005","unstructured":"Karumanchi SA, Maynard SE, Stillman IE, et al.: Preeclampsia: a renal perspective. Kidney Int 2005, 67:2101\u20132113.","journal-title":"Kidney Int"},{"key":"88_CR18","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1097\/01.ASN.0000141038.28733.F2","volume":"15","author":"A. Shimizu","year":"2004","unstructured":"Shimizu A, Masuda Y, Mori T, et al.: Vascular endothelial growth factor 165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 2004, 15:2655\u20132665.","journal-title":"J Am Soc Nephrol"},{"key":"88_CR19","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/labinvest.3700134","volume":"84","author":"K. Miyamoto","year":"2004","unstructured":"Miyamoto K, Kitamoto Y, Tokunaga H, et al.: Protective effect of vascular endothelial growth factor\/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Lab Invest 2004, 84:1126\u20131136.","journal-title":"Lab Invest"},{"key":"88_CR20","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/sj.ki.5000439","volume":"69","author":"A. Hara","year":"2006","unstructured":"Hara A, Wada T, Furuichi K, et al.: Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int 2006, 69:1986\u20131995.","journal-title":"Kidney Int"},{"key":"88_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","volume":"18","author":"E. Bujold","year":"2005","unstructured":"Bujold E, Romero R, Chaiworapongsa T, et al.: Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med 2005, 18:9\u201316.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"88_CR22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.placenta.2004.09.001","volume":"26","author":"A. Rajakumar","year":"2005","unstructured":"Rajakumar A, Michael HM, Rajakumar PA, et al.: Extraplacental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 2005, 26:563\u2013573.","journal-title":"Placenta"},{"key":"88_CR23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.RES.0000194324.29363.82","volume":"97","author":"O. Krysiak","year":"2005","unstructured":"Krysiak O, Bretschneider A, Zhong E, et al.: Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF. Circ Res 2005, 97:1253\u20131261.","journal-title":"Circ Res"},{"key":"88_CR24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1160\/TH05-03-0167","volume":"94","author":"S.K. Nadar","year":"2005","unstructured":"Nadar SK, Karalis I, Al Yemeni E, et al.: Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost 2005, 94:1071\u20131076.","journal-title":"Thromb Haemost"},{"key":"88_CR25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-2006-951626","volume":"38","author":"S. Koyama","year":"2006","unstructured":"Koyama S, Kimura T, Ogita K, et al.: Transient local overexpression of human vascular endothelial growth factor (VEGF) in mouse feto-maternal interface during midterm pregnancy lowers systemic maternal blood pressure. Hormone and Metabolic Research 2006, 38:619\u2013624.","journal-title":"Hormone and Metabolic Research"},{"key":"88_CR26","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.HYP.0000188701.24418.64","volume":"46","author":"R.I. Thadhani","year":"2005","unstructured":"Thadhani RI, Johnson RJ, Karumanchi SA: Hypertension during pregnancy: a disorder begging for pathophysiological support. Hypertension 2005, 46:1250\u20131251.","journal-title":"Hypertension"},{"key":"88_CR27","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","volume":"89","author":"R. Thadhani","year":"2004","unstructured":"Thadhani R, Mutter WP, Wolf M, et al.: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004, 89:770\u2013775.","journal-title":"J Clin Endocrinol Metab"},{"key":"88_CR28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"R.J. Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, et al.: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672\u2013683.","journal-title":"N Engl J Med"},{"key":"88_CR29","doi-asserted-by":"crossref","first-page":"R1085","DOI":"10.1152\/ajpregu.00794.2005","volume":"291","author":"O. Nevo","year":"2006","unstructured":"Nevo O, Soleymanlou N, Wu Y, et al.: Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006, 291:R1085\u2013R1093.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"88_CR30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.immuni.2004.10.011","volume":"21","author":"T.D. Eubank","year":"2004","unstructured":"Eubank TD, Roberts R, Galloway M, et al.: GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 2004, 21:831\u2013842.","journal-title":"Immunity"},{"key":"88_CR31","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/01.HYP.0000190040.66563.04","volume":"46","author":"T. Walther","year":"2005","unstructured":"Walther T, Wallukat G, Alexander J, et al.: Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 2005, 46:1275\u20131279.","journal-title":"Hypertension"},{"key":"88_CR32","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.HYP.0000256565.20983.d4","volume":"49","author":"C.A. Hubel","year":"2007","unstructured":"Hubel CA, Wallukat G, Wolf M, et al.: Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 2007, 49:612\u2013617.","journal-title":"Hypertension"},{"key":"88_CR33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.RES.0000254703.11154.18","volume":"100","author":"C.C. Zhou","year":"2007","unstructured":"Zhou CC, Ahmad S, Mi T, et al.: Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res 2007, 100:88\u201395.","journal-title":"Circ Res"},{"key":"88_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/156720206776875885","volume":"3","author":"A.K. Stennett","year":"2006","unstructured":"Stennett AK, Khalil RA: Neurovascular mechanisms of hypertension in pregnancy. Curr Neurovasc Res 2006, 3:131\u2013148.","journal-title":"Curr Neurovasc Res"},{"key":"88_CR35","doi-asserted-by":"crossref","first-page":"R916","DOI":"10.1152\/ajpregu.00406.2002","volume":"284","author":"Z.H. Zhang","year":"2003","unstructured":"Zhang ZH, Wei SG, Francis J, et al.: Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol 2003, 284:R916\u2013R927.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"88_CR36","doi-asserted-by":"crossref","first-page":"H2786","DOI":"10.1152\/ajpheart.2000.279.6.H2786","volume":"279","author":"S. Ye","year":"2000","unstructured":"Ye S, Mozayeni P, Gamburd M, et al.: Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am J Physiol Heart Circ Physiol 2000; 279:H2786\u2013H2796.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"88_CR37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/hy0202.102815","volume":"39","author":"V.M. Campese","year":"2002","unstructured":"Campese VM, Ye S, Zhong H: Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2002, 39:519\u2013524.","journal-title":"Hypertension"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-007-0088-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-007-0088-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-007-0088-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:19Z","timestamp":1559434459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-007-0088-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1007\/s11906-007-0088-1","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}